Meyer Handelman CO Edwards Lifesciences Corp Transaction History

Meyer Handelman CO

$2.92 Billion
Q3 2024

A detailed history of Meyer Handelman CO transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Meyer Handelman CO holds 34,608 shares of EW stock, worth $2.35 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

34,608

Previous 39,108 11.51%

Holding current value

$2.35 Million

Previous $3.61 Million 36.79%

% of portfolio

0.08%

Previous 0.13%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$59.7 - $93.78 $268,650 - $422,010	-4,500 Reduced 11.51%	34,608 $2.28 Million
Q1 2024 Apr 11, 2024	BUY	$72.54 - $95.56 $288,128 - $379,564	3,972 Added 11.3%	39,108 $3.74 Million
Q4 2023 Jan 17, 2024	SELL	$61.71 - $77.76 $277,695 - $349,920	-4,500 Reduced 11.35%	35,136 $2.68 Million
Q3 2023 Nov 06, 2023	BUY	$69.28 - $93.38 $644,304 - $868,434	9,300 Added 30.66%	39,636 $2.75 Million
Q2 2023 Jul 21, 2023	BUY	$81.41 - $94.33 $521,675 - $604,466	6,408 Added 26.78%	30,336 $2.86 Million
Q1 2023 Apr 11, 2023	SELL	$74.26 - $84.51 $475,858 - $541,540	-6,408 Reduced 21.12%	23,928 $1.98 Million
Q4 2021 Jan 25, 2022	BUY	$106.37 - $130.68 $630,561 - $774,671	5,928 Added 24.29%	30,336 $3.93 Million
Q1 2021 May 03, 2021	BUY	$78.68 - $90.67 $504,181 - $581,013	6,408 Added 35.6%	24,408 $2.04 Million
Q4 2020 Feb 03, 2021	BUY	$71.69 - $91.23 $344,112 - $437,904	4,800 Added 36.36%	18,000 $1.64 Million
Q2 2020 Jul 16, 2020	BUY	$57.54 - $76.95 $506,352 - $677,160	8,800 Added 200.0%	13,200 $912,000
Q3 2017 Oct 25, 2017	BUY	$36.29 - $38.83 $159,676 - $170,852	4,400	4,400 $481,000

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meyer Handelman CO, based on Form 13F filings with the SEC.

News

Stay updated on Meyer Handelman CO with notifications on news.

Account

Meyer Handelman CO Edwards Lifesciences Corp Transaction History